Management of Severe Ovarian Hyperstimulation Syndrome by Ascitic Fluid Aspiration and Intensive Intravenous Fluid Therapy
OBJECTIVE:To assess the value of intensive intravenous (IV) fluid therapy and ascitic fluid aspiration in the management of severe ovarian hyperstimulation syndrome. METHODS:Forty-two women with severe ovarian hyperstimulation syndrome were treated by ultrasonically guided transvaginal aspiration of...
Gespeichert in:
| Veröffentlicht in: | Obstetrics and gynecology (New York. 1953) 1993-01, Vol.81 (1), p.108-111 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 111 |
|---|---|
| container_issue | 1 |
| container_start_page | 108 |
| container_title | Obstetrics and gynecology (New York. 1953) |
| container_volume | 81 |
| creator | ABOULGHAR, MOHAMED A MANSOUR, RAGAA T SEROUR, GAMAL I SATTAR, MEHANY A AMIN, YAHIA M ELATTAR, INAS |
| description | OBJECTIVE:To assess the value of intensive intravenous (IV) fluid therapy and ascitic fluid aspiration in the management of severe ovarian hyperstimulation syndrome.
METHODS:Forty-two women with severe ovarian hyperstimulation syndrome were treated by ultrasonically guided transvaginal aspiration of ascitic fluid and IV fluid infusion. Ten women with the same condition treated conservatively constituted a comparison group. The main outcome measures included percentage change in hematocrit, creatinine clearance, and urine output before and after aspiration. The duration of hospital stay was compared between the groups.
RESULTS:Marked improvement of symptoms and general condition followed soon after aspiration. Hematocrit readings decreased by 22%, creatinine clearance increased by 79.3%, and urine output increased by 220.7%. The average volume of aspirated fluid was 3900 mL. The average duration of hospital stay was 3.8 days in the treated women. In the comparison group, severe symptoms and electrolyte imbalance continued for an average of 9 days, and the average hospital stay was 11 days.
CONCLUSION:Intensive IV fluid therapy and transvaginal aspiration of ascitic fluid are safe and effective in improving symptoms, preventing complications, and shortening the hospital stay in severe ovarian hyperstimulation syndrome. (Obstet Gynecol 1993;81:108-11) |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73497292</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73497292</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2801-b792580fd61803e84d7cf56d1477a26a212d0075f0f790211b0bb9a6ee5ace5f3</originalsourceid><addsrcrecordid>eNo9kUtLxTAQhYsoen38BCELcVfIq02zFFGvoLhQwV2ZtlNvNE1r0l6pv97ILS6GmcP5GIYze8mKFUqkXIi3_WRFKdepKqQ8So5D-KCUslyLw-SwkCyXkq-Sn0dw8I4dupH0LXnGLXokT1vwBhxZzwP6MJpusjCa3pHn2TW-75BUM7kKtRlNTW7tZJqoBuN3ELiG3LsRXTBb_Js8bNH1U1jQlw16GObT5KAFG_Bs6SfJ6-3Ny_U6fXi6u7--ekgHXlCWVkrzrKBtk7OCCixko-o2yxsmlQKeA2e8oVRlLW2VppyxilaVhhwxgxqzVpwkl7u9g--_Jgxj2ZlQo7XgMB5VKiG14ppH8HwBp6rDphy86cDP5RJW9C8WH0INtvXgahP-MZmpTCkRMbnDvns7xvg-7fSNvtwg2HFTxh_QnGc0ZVoLyqJKY3EmfgEVUITE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73497292</pqid></control><display><type>article</type><title>Management of Severe Ovarian Hyperstimulation Syndrome by Ascitic Fluid Aspiration and Intensive Intravenous Fluid Therapy</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>ABOULGHAR, MOHAMED A ; MANSOUR, RAGAA T ; SEROUR, GAMAL I ; SATTAR, MEHANY A ; AMIN, YAHIA M ; ELATTAR, INAS</creator><creatorcontrib>ABOULGHAR, MOHAMED A ; MANSOUR, RAGAA T ; SEROUR, GAMAL I ; SATTAR, MEHANY A ; AMIN, YAHIA M ; ELATTAR, INAS</creatorcontrib><description>OBJECTIVE:To assess the value of intensive intravenous (IV) fluid therapy and ascitic fluid aspiration in the management of severe ovarian hyperstimulation syndrome.
METHODS:Forty-two women with severe ovarian hyperstimulation syndrome were treated by ultrasonically guided transvaginal aspiration of ascitic fluid and IV fluid infusion. Ten women with the same condition treated conservatively constituted a comparison group. The main outcome measures included percentage change in hematocrit, creatinine clearance, and urine output before and after aspiration. The duration of hospital stay was compared between the groups.
RESULTS:Marked improvement of symptoms and general condition followed soon after aspiration. Hematocrit readings decreased by 22%, creatinine clearance increased by 79.3%, and urine output increased by 220.7%. The average volume of aspirated fluid was 3900 mL. The average duration of hospital stay was 3.8 days in the treated women. In the comparison group, severe symptoms and electrolyte imbalance continued for an average of 9 days, and the average hospital stay was 11 days.
CONCLUSION:Intensive IV fluid therapy and transvaginal aspiration of ascitic fluid are safe and effective in improving symptoms, preventing complications, and shortening the hospital stay in severe ovarian hyperstimulation syndrome. (Obstet Gynecol 1993;81:108-11)</description><identifier>ISSN: 0029-7844</identifier><identifier>EISSN: 1873-233X</identifier><identifier>PMID: 8416442</identifier><identifier>CODEN: OBGNAS</identifier><language>eng</language><publisher>New York, NY: The American College of Obstetricians and Gynecologists</publisher><subject>Ascites - etiology ; Ascites - therapy ; Biological and medical sciences ; Female ; Female genital diseases ; Fluid Therapy ; Gynecology. Andrology. Obstetrics ; Humans ; Infusions, Intravenous ; Medical sciences ; Non tumoral diseases ; Ovarian Hyperstimulation Syndrome - diagnosis ; Ovarian Hyperstimulation Syndrome - etiology ; Ovarian Hyperstimulation Syndrome - therapy ; Ovulation Induction - adverse effects ; Suction - methods</subject><ispartof>Obstetrics and gynecology (New York. 1953), 1993-01, Vol.81 (1), p.108-111</ispartof><rights>1993 The American College of Obstetricians and Gynecologists</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4575773$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8416442$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ABOULGHAR, MOHAMED A</creatorcontrib><creatorcontrib>MANSOUR, RAGAA T</creatorcontrib><creatorcontrib>SEROUR, GAMAL I</creatorcontrib><creatorcontrib>SATTAR, MEHANY A</creatorcontrib><creatorcontrib>AMIN, YAHIA M</creatorcontrib><creatorcontrib>ELATTAR, INAS</creatorcontrib><title>Management of Severe Ovarian Hyperstimulation Syndrome by Ascitic Fluid Aspiration and Intensive Intravenous Fluid Therapy</title><title>Obstetrics and gynecology (New York. 1953)</title><addtitle>Obstet Gynecol</addtitle><description>OBJECTIVE:To assess the value of intensive intravenous (IV) fluid therapy and ascitic fluid aspiration in the management of severe ovarian hyperstimulation syndrome.
METHODS:Forty-two women with severe ovarian hyperstimulation syndrome were treated by ultrasonically guided transvaginal aspiration of ascitic fluid and IV fluid infusion. Ten women with the same condition treated conservatively constituted a comparison group. The main outcome measures included percentage change in hematocrit, creatinine clearance, and urine output before and after aspiration. The duration of hospital stay was compared between the groups.
RESULTS:Marked improvement of symptoms and general condition followed soon after aspiration. Hematocrit readings decreased by 22%, creatinine clearance increased by 79.3%, and urine output increased by 220.7%. The average volume of aspirated fluid was 3900 mL. The average duration of hospital stay was 3.8 days in the treated women. In the comparison group, severe symptoms and electrolyte imbalance continued for an average of 9 days, and the average hospital stay was 11 days.
CONCLUSION:Intensive IV fluid therapy and transvaginal aspiration of ascitic fluid are safe and effective in improving symptoms, preventing complications, and shortening the hospital stay in severe ovarian hyperstimulation syndrome. (Obstet Gynecol 1993;81:108-11)</description><subject>Ascites - etiology</subject><subject>Ascites - therapy</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Fluid Therapy</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Infusions, Intravenous</subject><subject>Medical sciences</subject><subject>Non tumoral diseases</subject><subject>Ovarian Hyperstimulation Syndrome - diagnosis</subject><subject>Ovarian Hyperstimulation Syndrome - etiology</subject><subject>Ovarian Hyperstimulation Syndrome - therapy</subject><subject>Ovulation Induction - adverse effects</subject><subject>Suction - methods</subject><issn>0029-7844</issn><issn>1873-233X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kUtLxTAQhYsoen38BCELcVfIq02zFFGvoLhQwV2ZtlNvNE1r0l6pv97ILS6GmcP5GIYze8mKFUqkXIi3_WRFKdepKqQ8So5D-KCUslyLw-SwkCyXkq-Sn0dw8I4dupH0LXnGLXokT1vwBhxZzwP6MJpusjCa3pHn2TW-75BUM7kKtRlNTW7tZJqoBuN3ELiG3LsRXTBb_Js8bNH1U1jQlw16GObT5KAFG_Bs6SfJ6-3Ny_U6fXi6u7--ekgHXlCWVkrzrKBtk7OCCixko-o2yxsmlQKeA2e8oVRlLW2VppyxilaVhhwxgxqzVpwkl7u9g--_Jgxj2ZlQo7XgMB5VKiG14ppH8HwBp6rDphy86cDP5RJW9C8WH0INtvXgahP-MZmpTCkRMbnDvns7xvg-7fSNvtwg2HFTxh_QnGc0ZVoLyqJKY3EmfgEVUITE</recordid><startdate>199301</startdate><enddate>199301</enddate><creator>ABOULGHAR, MOHAMED A</creator><creator>MANSOUR, RAGAA T</creator><creator>SEROUR, GAMAL I</creator><creator>SATTAR, MEHANY A</creator><creator>AMIN, YAHIA M</creator><creator>ELATTAR, INAS</creator><general>The American College of Obstetricians and Gynecologists</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199301</creationdate><title>Management of Severe Ovarian Hyperstimulation Syndrome by Ascitic Fluid Aspiration and Intensive Intravenous Fluid Therapy</title><author>ABOULGHAR, MOHAMED A ; MANSOUR, RAGAA T ; SEROUR, GAMAL I ; SATTAR, MEHANY A ; AMIN, YAHIA M ; ELATTAR, INAS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2801-b792580fd61803e84d7cf56d1477a26a212d0075f0f790211b0bb9a6ee5ace5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Ascites - etiology</topic><topic>Ascites - therapy</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Fluid Therapy</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Infusions, Intravenous</topic><topic>Medical sciences</topic><topic>Non tumoral diseases</topic><topic>Ovarian Hyperstimulation Syndrome - diagnosis</topic><topic>Ovarian Hyperstimulation Syndrome - etiology</topic><topic>Ovarian Hyperstimulation Syndrome - therapy</topic><topic>Ovulation Induction - adverse effects</topic><topic>Suction - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ABOULGHAR, MOHAMED A</creatorcontrib><creatorcontrib>MANSOUR, RAGAA T</creatorcontrib><creatorcontrib>SEROUR, GAMAL I</creatorcontrib><creatorcontrib>SATTAR, MEHANY A</creatorcontrib><creatorcontrib>AMIN, YAHIA M</creatorcontrib><creatorcontrib>ELATTAR, INAS</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ABOULGHAR, MOHAMED A</au><au>MANSOUR, RAGAA T</au><au>SEROUR, GAMAL I</au><au>SATTAR, MEHANY A</au><au>AMIN, YAHIA M</au><au>ELATTAR, INAS</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of Severe Ovarian Hyperstimulation Syndrome by Ascitic Fluid Aspiration and Intensive Intravenous Fluid Therapy</atitle><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle><addtitle>Obstet Gynecol</addtitle><date>1993-01</date><risdate>1993</risdate><volume>81</volume><issue>1</issue><spage>108</spage><epage>111</epage><pages>108-111</pages><issn>0029-7844</issn><eissn>1873-233X</eissn><coden>OBGNAS</coden><abstract>OBJECTIVE:To assess the value of intensive intravenous (IV) fluid therapy and ascitic fluid aspiration in the management of severe ovarian hyperstimulation syndrome.
METHODS:Forty-two women with severe ovarian hyperstimulation syndrome were treated by ultrasonically guided transvaginal aspiration of ascitic fluid and IV fluid infusion. Ten women with the same condition treated conservatively constituted a comparison group. The main outcome measures included percentage change in hematocrit, creatinine clearance, and urine output before and after aspiration. The duration of hospital stay was compared between the groups.
RESULTS:Marked improvement of symptoms and general condition followed soon after aspiration. Hematocrit readings decreased by 22%, creatinine clearance increased by 79.3%, and urine output increased by 220.7%. The average volume of aspirated fluid was 3900 mL. The average duration of hospital stay was 3.8 days in the treated women. In the comparison group, severe symptoms and electrolyte imbalance continued for an average of 9 days, and the average hospital stay was 11 days.
CONCLUSION:Intensive IV fluid therapy and transvaginal aspiration of ascitic fluid are safe and effective in improving symptoms, preventing complications, and shortening the hospital stay in severe ovarian hyperstimulation syndrome. (Obstet Gynecol 1993;81:108-11)</abstract><cop>New York, NY</cop><pub>The American College of Obstetricians and Gynecologists</pub><pmid>8416442</pmid><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0029-7844 |
| ispartof | Obstetrics and gynecology (New York. 1953), 1993-01, Vol.81 (1), p.108-111 |
| issn | 0029-7844 1873-233X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73497292 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Ascites - etiology Ascites - therapy Biological and medical sciences Female Female genital diseases Fluid Therapy Gynecology. Andrology. Obstetrics Humans Infusions, Intravenous Medical sciences Non tumoral diseases Ovarian Hyperstimulation Syndrome - diagnosis Ovarian Hyperstimulation Syndrome - etiology Ovarian Hyperstimulation Syndrome - therapy Ovulation Induction - adverse effects Suction - methods |
| title | Management of Severe Ovarian Hyperstimulation Syndrome by Ascitic Fluid Aspiration and Intensive Intravenous Fluid Therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T17%3A29%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20Severe%20Ovarian%20Hyperstimulation%20Syndrome%20by%20Ascitic%20Fluid%20Aspiration%20and%20Intensive%20Intravenous%20Fluid%20Therapy&rft.jtitle=Obstetrics%20and%20gynecology%20(New%20York.%201953)&rft.au=ABOULGHAR,%20MOHAMED%20A&rft.date=1993-01&rft.volume=81&rft.issue=1&rft.spage=108&rft.epage=111&rft.pages=108-111&rft.issn=0029-7844&rft.eissn=1873-233X&rft.coden=OBGNAS&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E73497292%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73497292&rft_id=info:pmid/8416442&rfr_iscdi=true |